Sentinel node dissection in prostate cancer - Current status;Sentinel-lymphadenektomie beim prostatakarzinom - Aktueller stand

Urologe - Ausgabe A

Volumn 46, Issue 11, 2007, Pages 1500-1507

  Weckermann, D ^a   Holl, G ^a   Wagner, T ^a   Harzmann, R ^a  

^a KLINIKUM AUGSBURG   (Germany)

Author keywords

Pelvic lymphadenectomy; Prostate cancer; Sentinel lymph node

Indexed keywords

CANCER DIAGNOSIS; CANCER RISK; CANCER STAGING; HIGH RISK PATIENT; HORMONAL THERAPY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; PROSTATE CANCER; REVIEW; SENTINEL LYMPH NODE; TRANSURETHRAL RESECTION;

HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; PROGNOSIS; PROSTATIC NEOPLASMS; SENTINEL LYMPH NODE BIOPSY;

EID: 36249023168     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-007-1564-6     Document Type: Review

References (29)

1. Allaf ME, Palaputtu GS, Trock BJ et al. (2004) Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J Urol 172: 1840-1844
2. Bader P, Burkhard FC, Markwalder R, Studer UE (2002) Is a limited lymph node dissection an adequate staging procedure for prostate cancer? J Urol 168: 514-518
3. Bader P, Spahn M, Woehr M, Frohneberg D (2007) Extent of lymph node dissection in correlation to percentage of detected lymph node metastases and progression. J Urol (Suppl) 177: 463; 1406
4. Bastide C, Brenot-Rossi I, Garcia S et al. (2004) Feasibility and value of the isotope sentinel node mapping technique in prostate cancer. Prog Urol 14: 501-506
5. Beri A, Janetschek G (2006) Technology insight: radioguided sentinel lymph node dissection in the staging of prostate cancer. Nat Clin Pract Urol 3: 602-610
6. Brenot-Rossi I, Bastide C, Garcia S et al. (2005) Limited pelvic lymphadenectomy using the sentinel lymph node procedure in patients with localised prostate carcinoma: a pilot study. Eur J Nucl Med Mol Imaging 32: 635-640
7. Burkhard FC, Schumacher M, Thalmann GN, Studer UE (2005) Is pelvic lymphadenectomy really necessary in patients with a serum prostate-specific antigen level of <10 ng/ml undergoing radical prostatectomy for prostate cancer? BJU Int 95: 275-278
8. Corvin S, Schilling D, Eichhorn K et al. (2006) Laparoscopic sentinel lymph node dissection - a novel technique for the staging of prostate cancer. Eur Urol 49: 280-285
9. Daneshmand S, Quek ML, Stein JP et al. (2004) Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. J Urol 172: 2252-2255
10. Fukuda M, Egawa M, Imao T et al. (2007) Detection of sentinel node micrometastasis by step section and immunohistochemistry in patients with prostate cancer. J Urol 177: 1313-1317
11. Ganswindt U, Paulsen F, Corvin S et al. (2007) Optimized coverage of high-risk adjuvant lymph node areas in prostate cancer using a sentinel node-based, intensity-modulated radiation therapy technique. Int J Radiat Oncol Biol Phys 67: 347-355
12. Gould EA, Winship T, Philbin PH, Kerr HH (1960) Observations on a.,sentinel node" in cancer of the parotid. Cancer 13: 77-78
13. Haas CJ, Wagner T, Wawroschek F, Arnholdt H (2005) Combined application of RT-PCR and immunohistochemistry on paraffin embedded sentinel lymph nodes of prostate cancer patients. Pathol Res Pract 200: 763-770
14. 18F]Fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection. J Urol 176: 2014-2019
15. Heidenreich A, Varga Z, Knobloch R von (2002) Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol 167: 1681-1886
16. Jeschke S, Beri A, Grull M et al. (in press) Laparoscopic radioisotope-guided sentinel lymph node dissection in staging of prostate cancer. Eur Urol, epub ahead of print
17. Rudoni M, Sacchetti GM, Leva L et al. (2002) Recent applications of the sentinel lymph node concept: preliminary experience in prostate cancer. Tumori 88: 16-17
18. Silva N, Anselmi CE, Anselmi OE et al. (2005) Use of the gamma probe in sentinel lymph node biopsy in patients with prostate cancer. Nucl Med Commun 26: 1081-1086
19. Takashima H, Egawa M, Imao T et al. (2004) Validity of sentinel lymph node concept for patients with prostate cancer. J Urol 171: 2268-2271
20. Vogt H, Wawroschek F, Wengenmair H et al. (2002) Sentinel lymph node diagnostic in prostate carcinoma: Part I: Technique and clinical evaluation. Nuklearmedizin 41: 95-101
21. Wawroschek F, Vogt H, Weckermann D et al. (1999) The sentinel lymph node concept in prostate cancer - first results of gamma probe-guided sentinel lymph node identification. Eur Urol 36: 595-600
22. Wawroschek F, Vogt H, Weckermann D et al. (2001) Radioisotope guided pelvic lymph node dissection for prostate cancer. J Urol 166: 1715-1719
23. Wawroschek F, Vogt H, Wengenmair H et al. (2003) Prostate lymphoscintigraphy and radio-guided surgery for sentinel lymph node identification in prostate cancer. Urol Int 70: 303-310
24. Wawroschek F, Wagner T, Hamm M et al. (2003) The influence of serial sections, immunohistochemistry, and extension of pelvic lymph node dissection on the lymph node status in clinically localized prostate cancer. Eur Urol 43: 132-137
25. Weckermann D, Dorn R, Holl G et al. (2007) Limitations of radioguided surgery in high-risk prostate cancer. Eur Urol 51: 1549-1558
26. Weckermann D, Dorn R, Trefz M et al. (2007) Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients. J Urol 177: 916-920
27. Weckermann D, Holl G, Dorn R et al. (2007) Reliability of preoperative diagnostics and location of lymph node metastases in presumed unilateral prostate cancer. BJU Int 99: 1036-1040
28. Weiss M, Gildenhaus FJ, Brinkbäumer K et al. (2005) Lymph kinetics with technetium-99m labeled radiopharmaceuticals. Animal studies. Nuklearmedizin 44: 156-165
29. 99mTc-Nanocolloid after intraprostatic injection. Nuklearmedizin 41: 102-107